ROBOS '25, The 7th Raab Outer Banks Oncology Symposium: Late Morning Sessions, July 11

Advances in Radiation Therapy for Primary Liver Cancer.

Cuneo KC, Herr DJ.

Surg Oncol Clin N Am. 2023 Jul;32(3):415-432. doi: 10.1016/j.soc.2023.02.002. Epub 2023 Apr 4.

PMID: 37182985 Review.

Electrochemotherapy in the Locoregional Treatment of Metastatic Colorectal Liver Metastases: A Systematic Review.

Barbieri P, Posa A, Lancellotta V, Madoff DC, Maresca A, Cornacchione P, Tagliaferri L, Iezzi R.

Curr Oncol. 2024 Nov 20;31(11):7403-7413. doi: 10.3390/curroncol31110546.

PMID: 39590176 Free PMC article. Review.

2.

Identifying subgroups deriving the most benefit from PD-1 checkpoint inhibition plus chemotherapy in advanced metastatic triple-negative breast cancer: a systematic review and meta-analysis.

Lin S, Fu B, Khan M.

World J Surg Oncol. 2024 Dec 21;22(1):346. doi: 10.1186/s12957-024-03424-3.

PMID: 39709499 Free PMC article. Review.

3.

The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials.

Pu W, Li S, Zhang J, Huang J, Li J, Jiang Y, Xu Z, Yi F, Lan Y, Xiao Q, Chen W, Jin J.

Front Immunol. 2025 Mar 26;16:1566939. doi: 10.3389/fimmu.2025.1566939. eCollection 2025.

PMID: 40207218 Free PMC article.

4.

Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review.

Miller ED, Klamer BG, Cloyd JM, Pawlik TM, Williams TM, Hitchcock KE, Romesser PB, Mamon HJ, Ng K, Gholami S, Chang GJ, Anker CJ.

Clin Colorectal Cancer. 2024 Jun;23(2):160-173. doi: 10.1016/j.clcc.2024.01.004. Epub 2024 Jan 30.

PMID: 38365567

5.

Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis.

Li Z, Li Q, Wang X, Li S, Chen W, Jin X, Liu X, Dai Z, Liu X, Zheng X, Li P, Zhang H, Zhang Q, Luo H, Liu R.

Front Public Health. 2021 Dec 9;9:767617. doi: 10.3389/fpubh.2021.767617. eCollection 2021.

PMID: 34957022 Free PMC article.

6.

Selective internal radiation therapy for hepatic metastases of uveal melanoma: a systematic review.

Alexander H, Wen D, Chu M, Han C, Hadden P, Thomas R, Bartlett A.

Br J Radiol. 2022 Jan 1;95(1129):20210200. doi: 10.1259/bjr.20210200. Epub 2021 Nov 10.

PMID: 34757824 Free PMC article.

Current research of the Notch pathway in hepatocellular carcinoma.

Fu L, Gu X, Lou N, Li J, Xue C.

Eur J Med Res. 2025 May 20;30(1):402. doi: 10.1186/s40001-025-02626-z.

PMID: 40394648 Free PMC article. Review.

2.

TGF-β1 induces autophagy and mediates the effect on macrophages differentiation in primary liver cancer.

Liu C, Li M, Liu L, Xu Q, Zheng L, Wu C, Ren J, Zhang T, Wang H, Lin Z.

Int Immunopharmacol. 2025 Jun 5;157:114799. doi: 10.1016/j.intimp.2025.114799. Epub 2025 May 7.

PMID: 40339499

3.

CT-guided high-dose-rate brachytherapy ablation of HCC patients with portal vein tumor thrombosis.

Auer TA, Ranner-Hafferl MHH, Anhamm M, Böning G, Fehrenbach U, Mohr R, Geisel D, Kloeckner R, Gebauer B, Collettini F.

Eur Radiol Exp. 2025 Feb 14;9(1):16. doi: 10.1186/s41747-025-00564-3.

PMID: 39951200 Free PMC article.

4.

Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.

Tang L, Yang X, He L, Zhu C, Chen Q.

Lipids Health Dis. 2025 Jan 31;24(1):31. doi: 10.1186/s12944-024-02429-x.

PMID: 39891269 Free PMC article. Review.

5.

Effect of peripheral blood lymphocyte count on the efficacy of immunotherapy combined with TKI in the treatment of advanced liver cancer.

Zhao Q, Wang L, Fu H, Zhang Y, Xie Q.

Front Immunol. 2024 Oct 24;15:1467429. doi: 10.3389/fimmu.2024.1467429. eCollection 2024.

PMID: 39512348 Free PMC article.

6.

Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment.

Liu Y, Yang H, Li T, Zhang N.

Front Immunol. 2024 Sep 3;15:1460282. doi: 10.3389/fimmu.2024.1460282. eCollection 2024.

PMID: 39295859 Free PMC article. Review.

7.

The current status and future of targeted-immune combination for hepatocellular carcinoma.

Hao L, Li S, Ye F, Wang H, Zhong Y, Zhang X, Hu X, Huang X.

Front Immunol. 2024 Aug 5;15:1418965. doi: 10.3389/fimmu.2024.1418965. eCollection 2024.

PMID: 39161764 Free PMC article. Review.

8.

Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets.

Rahman MA, Rakib-Uz-Zaman SM, Chakraborti S, Bhajan SK, Gupta RD, Jalouli M, Parvez MAK, Shaikh MH, Hoque Apu E, Harrath AH, Moon S, Kim B.

Cells. 2024 Jul 12;13(14):1186. doi: 10.3390/cells13141186.

PMID: 39056768 Free PMC article. Review.

9.

Dosimetric comparison of proton therapy and CyberKnife in stereotactic body radiation therapy for liver cancers.

Shyllon S, Penfold S, Dalfsen R, Kirkness E, Hug B, Rowshanfarzad P, Devlin P, Tang C, Le H, Gorayski P, Grogan G, Kearvell R, Ebert MA.

Phys Eng Sci Med. 2024 Sep;47(3):1203-1212. doi: 10.1007/s13246-024-01440-x. Epub 2024 May 29.

PMID: 38809365 Free PMC article.